14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock News

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Moderna (MRNA) Received its Third Buy in a Row

02:08pm, Tuesday, 21'st Apr 2020
After Chardan Capital and Needham gave Moderna (NASDAQ: MRNA) a Buy rating last month, the company received another Buy, this
After Merrill Lynch and Canaccord Genuity gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
After Merrill Lynch and Canaccord Genuity gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another
The time-lapse video includes footage of engineers and welders working together to construct the facility which was reportedly built to international standards.
Oppenheimer analyst Hartaj Singh maintained a Buy rating on United Therapeutics (UTHR) today and set a price target of $155.00. The company's shares
Oppenheimer analyst Hartaj Singh maintained a Buy rating on United Therapeutics (UTHR – Research Report) today and set a price
They need to visit any Rivoli EyeZone store across the country and present their work ID to avail of the offer
In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Catabasis Pharmaceuticals (CATB – Research Report),
Last month, Cafu committed free fuel for all ambulances operated by Dubai Corporation for Ambulance Services (DCAS) for a period of two weeks
The United Arab Emirates’ embassy in New Delhi said on Saturday it succeeded in obtaining the
Catabasis Pharmaceuticals to Present at 2020 Muscular Dystrophy Association Virtual Poster Session
Emirates have introduced coronavirus blood tests for passengers, a first for airlines, the company
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roche Holding AG (RHHVF), Moderna (MRNA) and Sanofi (SNYNF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roche Holding AG ( RHHVF – Research Report ), Moderna ( MRNA – Research Report ) and Sanofi ( SNYNF
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Gilead Sciences (GILD) today. The company's shares closed last Monday at $75.08. According to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE